Related Experiment Video
Updated: May 21, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered
Catherine Maude Pound1, Camillia Clark, Andy Ni
1Department of Pediatrics, Division of Pediatric Medicine, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada. cpound@cheo.on.ca
Insights
High-dose corticosteroids significantly impact behavior and quality of life in children undergoing acute lymphoblastic leukemia (ALL) maintenance therapy. These effects, including emotional disturbances and increased pain, necessitate careful consideration during treatment.
Area of Science:
- Pediatric Oncology
- Clinical Psychology
- Pharmacology
Background:
- Children with acute lymphoblastic leukemia (ALL) often receive high-dose corticosteroids during maintenance therapy.
- Corticosteroids are crucial for ALL treatment but may have significant side effects.
- Understanding the impact on behavior and quality of life is essential for supportive care.
Purpose of the Study:
- To investigate the effects of high-dose corticosteroids on behavior and quality of life in pediatric ALL patients during maintenance therapy.
- To compare the effects of different corticosteroids (dexamethasone vs. prednisone) on behavior in older children.
- To evaluate changes in behavior and quality of life when children are on versus off steroids.
Main Methods:
- A cohort of 43 families (patient and/or parent) participated.
- Children served as their own controls, completing questionnaires on and off steroids.
- Validated instruments included the Child Behavior Checklist (CBCL) and the Pediatric Quality of Life Inventory (PedsQL) Cancer module.
Main Results:
- Younger children (≤5 years) showed significantly higher CBCL scores for somatic complaints, affective problems, internalizing, externalizing, and total problems when on steroids.
- Older children (≥6 years) exhibited higher CBCL scores for externalizing, aggressive, and oppositional defiant problems on steroids.
- Parents reported increased pain, nausea, and procedural anxiety on PedsQL when children were on steroids; older children had greater behavioral changes with dexamethasone compared to prednisone.
Conclusions:
- Corticosteroid treatment during ALL maintenance therapy is linked to behavioral and emotional disturbances.
- These medications adversely affect the quality of life for children with ALL.
- Dexamethasone is associated with more pronounced behavioral changes in older children, suggesting differential effects based on age and drug type.
Abstract:
The aim of this study was to investigate the effects of high-dose corticosteroids on behavior and quality of life of children with acute lymphoblastic leukemia (ALL) in maintenance therapy. Forty-three families (patient and/or parent) completed the Child Behavior Checklist (CBCL), the Pediatric Quality of Life Inventory (PedsQL) Cancer module questionnaires, a checklist of common complaints, and a descriptive intervention data questionnaire, on and off steroids, each child serving as his/her own control. Children 5 years and younger had higher CBCL scores in the somatic complaints, affective problems, internalizing, externalizing, and total problem scales, when comparing "on-steroid" to "off-steroid" periods (P<0.01). Children 6 years and above had higher CBCL scores in the externalizing, aggressive, and oppositional defiant problem scales on steroids compared with off steroids (P<0.05). Older children had larger changes on dexamethasone, compared with prednisone (P<0.05). On the PedsQL questionnaire, parents reported more pain and hurt (P<0.001), nausea (P=0.042), and procedural anxiety (P=0.013) when children were on steroids compared with off steroids. Corticosteroid treatment during ALL maintenance therapy is associated with behavior and emotional disturbances and adversely affects quality of life. Dexamethasone is associated with more significant behavioral changes in older children.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Treatment Resistant Cancers
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
